The programme features leading speakers, including:

Dr Peter Kalinka, Managing Director, Accelsiors Group
Don Baim, MD, Brigham & Women’s Hospital
Dr Steven Chmielewski, Manager, Project Management Excellent,  Preferred CRO Partnerships, Eli Lilly  
Mark Engel, President & CEO, Excel PharmaStudies
Dr. Larry Blankstein, Senior Director, Clinical Research, Genzyme
Dennis LaCroix, Director & Senior Counsel, Clinical Contracts & Vendor, Genzyme 
Spencer Goldsmith, President, Harvard Clinical Research Institute
Dr Richard Kuntz, MD, MSc., HCRI
Dr David Cohen, MD, HCRI
Ann Wang, Vice President, Clinical Operations, Human Genome Sciences Inc
Alex Milstein, Director, Clinical Research and Development, Medtronic Vascular
Tom Sommer, President, MassMEDIC
Alek Safarian, CEO, Novotech
Maria Buckley, Nutter McClennen & Fish LLP
Ilonna Rimm, Oxford Bioscience
Nancy Briefs, CEO, Percardia
Dr Paul Bleicher, Chairman & Founder, Phase Forward
Kevin Connors, Spray Partners
Lynn McGovern, Director Outsourcing, Synta Pharmaceuticals Group
Dr Christopher Milne, Assistant Director, Tufts Centre for Drug Development